Prudential Financial
STRO icon

Prudential Financial’s Sutro Biopharma STRO Stock Holding History

Prudential Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,550
Closed -$30.8K – 2434
2025
Q3 		$30.8K Hold
3,550
– – ﹤0.01% 2383
2025
Q2 		$25.3K Sell
3,550
-56,908
-94% -$465K ﹤0.01% 2387
2025
Q1 		$393K Buy
60,458
+5,707
+10% +$89.9K ﹤0.01% 1918
2024
Q4 		$1.01M Buy
54,751
+42,610
+351% +$1.3M ﹤0.01% 1569
2024
Q3 		$420K Buy
12,141
+1,610
+15% +$63.1K ﹤0.01% 2283
2024
Q2 		$309K Buy
10,531
+2,889
+38% +$114K ﹤0.01% 2343
2024
Q1 		$432K Sell
7,642
-9,280
-55% -$410K ﹤0.01% 2222
2023
Q4 		$726K Buy
16,922
+6,423
+61% +$204K ﹤0.01% 1970
2023
Q3 		$364K Buy
10,499
+980
+10% +$42.7K ﹤0.01% 2192
2023
Q2 		$443K Buy
9,519
+8,080
+562% +$402K ﹤0.01% 2174
2023
Q1 		$66.5K Buy
1,439
+280
+24% +$17.8K ﹤0.01% 2477
2022
Q4 		$93.6K Buy
1,159
+152
+15% +$10.6K ﹤0.01% 2454
2022
Q3 		$56K Buy
+1,007
New +$59.6K ﹤0.01% 2553

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Prudential Financial's STRO Position: Q4 2025 in Review

Prudential Financial sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 3,550 shares — an estimated $30.8K sold.

Prudential Financial first reported a position in STRO in Q3 2022 and held it in 13 quarters. The position peaked at $1.01M in Q4 2024. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • Prudential Financial reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • Prudential Financial sold 3,550 Sutro Biopharma shares in Q4 2025, an estimated $30.8K.
  • Prudential Financial first reported a position in Sutro Biopharma in Q3 2022 and held it in 13 quarters.
  • Prudential Financial's Sutro Biopharma position peaked at $1.01M in Q4 2024.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.